Skip Navigation

Cardiovascular Research 2007 76(2):323-330; doi:10.1016/j.cardiores.2007.06.025
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Häusler, M.
Right arrow Articles by Kleines, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Häusler, M.
Right arrow Articles by Kleines, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

Myocarditis in newborn wild-type BALB/c mice infected with the murine gamma herpesvirus MHV-68

Martin Häuslera,*, Bernd Sellhausb, Simone Scheithauerc, Bärbel Gaidaa,b, Sabrina Kuropkac, Katharina Siepmanna,b, Anna Panekb, Wibke Berga,c, Andreas Teubnerd, Klaus Ritterc and Michael Kleinesc

aDepartment of Pediatrics, University Hospital, RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany
bDepartment of Neuropathology, University Hospital, RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany
cDivision of Virology/Institute of Medical Microbiology, University Hospital, RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany
dInstitute of Laboratory Animal Science, University Hospital, RWTH Aachen, Pauwelsstr. 30, 52074 Aachen, Germany

*Corresponding author. Tel.: +49 241 800; fax: +49 241 8082484. Haeusler{at}rwth-aachen.de

Objectives Animal models of human Epstein–Barr virus (EBV) infection include EBV infection of primates and infection of mice with MHV-68, a further gamma herpesvirus ({delta}-HV). We aimed at extending the MHV-68 model to study {delta}-HV-related cardiac disease.

Methods Newborn wild-type BALB/c- (n=107), wild-type C57BL/6- (n=17) and immunodeficient B6-(Rag1)TM mice (n=18) were infected by nasal inoculation and evaluated for histopathological changes as well as tissue viral loads.

Results From day 5 on BALB/c mice showed myocardial viral replication. Whereas focal inflammation occurred simultaneously, necrosis was first observed 9 days post-infection. The maximum rates of necrosis (40%) and of focal inflammation (33%) were found after 10 to 12 and 33 to 35 days, respectively. Some animals developed persistent viral activity and inflammation throughout the observation period of three months. Inflammation was mainly related to T cell infiltrates. Although C57BL/6 mice also showed myocardial inflammation, necrosis was not found suggesting differences in the susceptibility to the virus in distinct mouse strains. In immunodeficient animals higher myocardial viral loads were observed compared to wild-type mice but no cardiac lesions, which suggests that the antiviral immune response contributed to the lesions.

Conclusions The model system presented here is the first to allow detailed studies on cardiac disease caused by {delta}-HV infections and may facilitate the development of more specific treatment options for human cardiac EBV infection.

KEYWORDS Murine gammaherpesvirus 68; MHV-68; Epstein–Barr virus; Myocarditis; Animal model; Mouse


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
C. Ptaschinski and R. Rochford
Infection of neonates with murine gammaherpesvirus 68 results in enhanced viral persistence in lungs and absence of infectious mononucleosis syndrome
J. Gen. Virol., May 1, 2008; 89(5): 1114 - 1121.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.